Bruker Corporation (BRKR)
$56.98-4.33%Close
SELLRECOVERY · day 10
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $8.7B
- Avg volume
- 2.4M
- Beta
- 1.27
- Div yield
- 0.43%
- P/E (TTM)
- -81.80
- Short % float
- 12.25%
- Days to cover
- 6.5
- SI change
- -13.3%
- 1W
- -1.20%
- 1M
- -5.74%
- 3M
- +24.71%
- YTD
- +18.44%
- vs SPY 1W
- -0.01%
- vs SPY 1M
- -9.06%
- vs SPY 3M
- +22.32%
- vs SPY YTD
- +6.68%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AXSMSELLAxsome Therapeutics, Inc.BEARQ 35$205.40-1.14%
- EMBCBUYEmbecta Corp.RECOVERYQ -28$4.99-4.59%
- TRLVBUYRECOVERYQ 14$11.14+0.36%
- PTGXBUYProtagonist Therapeutics, Inc.BULLQ 33$154.72+0.26%
- AGENBUYAgenus Inc.RECOVERYQ -1$7.67-5.19%
- FPCGBUYAvem Health Partners, Inc.BULLQ 6$1025.00+0.00%
- FONRBUYFONAR CorporationBULLQ 12$19.09+0.00%
- TVTXBUYTravere Therapeutics, Inc.BULLQ 34$65.22-0.75%
- SPOKSELLSpok Holdings, Inc.RECOVERYQ 13$10.62+3.01%
- PRGOBUYPerrigo Company plcRECOVERYQ 1$14.27+0.14%
- OGIBUYOrganigram Global Inc.RECOVERYQ 5$1.26+0.80%
- SRTABUYStrata Critical Medical, Inc.RECOVERYQ 1$5.97-4.33%
Industry peers
FMP comparable companies · ranked by market cap
- BTSGSELLBrightSpring Health Services, Inc. Common Stock$11.7BBEARQ 77$59.53+1.05%
- GKOSBUYGlaukos Corporation$10.9BBULLQ 20$184.89+0.41%
- KRYSSELLKrystal Biotech, Inc.$9.9BRECOVERYQ 47$337.02-1.40%
- TGTXBUYTG Therapeutics, Inc.$7.7BRECOVERYQ 11$50.56+3.21%
- CHEBUYChemed Corporation$7.0BBULLQ 19$534.88+0.14%
- TFXBUYTeleflex Incorporated$6.0BBULLQ 10$134.96-0.37%
- CRSPBUYCRISPR Therapeutics AG$5.6BRECOVERYQ 21$58.12-4.07%
- MMSIBUYMerit Medical Systems, Inc.$5.4BBULLQ 13$90.27-0.55%
- IRTCBUYiRhythm Technologies, Inc.$4.2BRECOVERYQ 26$127.98-2.54%
- TMDXBUYTransMedics Group, Inc.$3.1BRECOVERYQ 28$90.85-1.23%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 23
- VALUE
- 0
- GROWTH
- 43
- GARP
- 33
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-1.8%
REV YoY-
ROE-2.9%
EPS YoY-
ROA-1.2%
GROSS47
OP4
NET-2
[VALUATION]
P/E TTM-81.80
P/E FWD27.18
SECTOR PE22.62
INDUSTRY PE24.57
P/B3.63
P/FCF-
EV/EBITDA42.16
EV/EBIT-
PEG2.13
FCF YIELD-
RISK
INT COV-
D/E79.81
ALTMAN Z-
CURR RATIO1.85
ND/EBITDA-
BETA1.27
